Eli Lilly and Company vs Merck & Company, Inc. — Stock Comparison
Eli Lilly and Company (LLY) and Merck & Company, Inc. (MRK) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Eli Lilly and Company scores ahead of Merck & Company, Inc. on Q·Score (8 vs 6.9 out of 10), led by Growth (9.7 vs 6.2) and Quality (9 vs 7.7). Merck & Company, Inc. scores higher on Valuation, reflecting stronger P/E and price-target positioning. Analyst consensus targets imply greater upside for MRK (+7.8%) than for LLY (+5.5%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Earnings growing 170% year-over-year on 56% revenue growth.
High-quality business with 19% return on equity and 14% profit margins.
Analyst Consensus
Fundamentals
Frequently Asked Questions
LLY vs MRK: which stock scores better overall?
Based on Q·Score, Eli Lilly and Company (LLY) scores 8/10 versus Merck & Company, Inc. (MRK) at 6.9/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: LLY or MRK?
Eli Lilly and Company (LLY) scores higher on Growth (9.7/10 vs 6.2/10). Eli Lilly and Company reports revenue growth (55.5% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is LLY or MRK more attractively valued?
Merck & Company, Inc. (MRK) scores higher on Valuation (6.4/10 vs 6.3/10). LLY trades at 25.9× P/E versus MRK at 12.6×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about LLY vs MRK?
There are 29 analysts covering LLY with a consensus price target of $1215.79, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: LLY or MRK?
Eli Lilly and Company (LLY) scores higher on Quality (9/10 vs 7.7/10). Net profit margin: LLY at 35.0%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: LLY or MRK?
Eli Lilly and Company (LLY) scores higher on Financial Health (7/10 vs 7/10). Market beta: LLY at 0.52, MRK at 0.22. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of LLY and MRK?
Eli Lilly and Company (LLY) has a market capitalisation of $1.03T, while Merck & Company, Inc. (MRK) has a market cap of $297.1B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do LLY or MRK pay dividends?
LLY pays a dividend yield of 0.60%, while MRK pays a dividend yield of 2.82%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →